Market Performance of Disc Medicine (IRON)

  • Price movement – During the 24‑hour period ending at 10:49 AM Central Europe on Wednesday 21 March, Disc Medicine’s share price increased by 38.86 %.
  • Current trading price – The share is trading at USD 79.48 on major exchanges.
  • Outstanding shares – The company has 38.4 million shares outstanding.
  • Market capitalization – Disc Medicine’s market value stands at USD 3 billion.
  • Volume – In the last 24 hours, approximately USD 669.3 million of Disc Medicine shares have been traded.
  • Monthly performance – Since the end of the previous month, the stock has risen 15.24 %.
  • Technical indicators
  • 200‑day simple moving average: USD 70.66.
  • 52‑week high: USD 99.50 (recorded 12 August 2025).
  • 52‑week low: USD 40.00 (recorded 13 February 2026).

SymbolTicker% ChangeCurrent Price (USD)Market Cap (USD)P/E Ratio
ItronITRI–1.08 %84.623.6 billion13.91
Arcutis BiotherapeuticsARQT+10.65 %32.823.6 billion132.45
Organon &OGN–0.07 %13.763.6 billion17.37
FreshworksFRSH+2.84 %14.853.6 billion18.75
IrhythmIRTC0 %113.853.6 billion–

Freshworks (FRSH) – The stock has recently reached new 52‑week highs and received a strong buy recommendation from technical analysts. Analysts project modest earnings growth for the current and following year, with revenue expected to trend upward. Market sentiment remains positive, though some advisors advise caution regarding valuation dynamics. Overall, Freshworks is regarded as a solid growth and profitability candidate, with investors encouraged to monitor valuation closely.


Company Overview

Disc Medicine, Inc. is a clinical‑stage biopharmaceutical firm headquartered in Watertown, United States. The company focuses on developing and commercializing novel therapies for serious hematologic diseases by targeting key biological pathways involved in red blood cell biology. More information is available on the company’s website at www.discmedicine.com . The stock trades on the Nasdaq under the ticker IRON.